Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild…
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild…
Ardelyx has dosed the first patient in the ACCEL (ten-03-301) Phase III clinical trial evaluating Ibsrela (tenapanor) to treat chronic…